Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed4
Terminated2

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT05233098Completed
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2022-04-04
NCT03052049Not ApplicableCompleted
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
Benign Prostatic Hyperplasia (BPH)
PrincipalinvestigatorStart date: 2017-09-06
NCT03059030Not ApplicableTerminated
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
CirrhosisThrombocytopenia
PrincipalinvestigatorStart date: 2017-03-16
NCT03295006Completed
A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2016-10-31
NCT01887717Phase 3Terminated
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2014-02-27

Research Network

Collaboration Network

12 collaborators·24 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCirrhosisCancer of Liver
Similarity Score18%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCirrhosisCancer of Liver
Similarity Score18%

Kush Desai, MD

Northwestern University

Related
3 trials

Shared therapeutic areas:

Benign Prostatic Hyperplasia

Worked with same sponsors:

BTG International Inc.Northwestern University
Collaborated on 1 trial
Similarity Score14%

Marnix Lam, MD, PhD

Universitair Medisch Centrum Utrecht

Related
1 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular

Worked with same sponsors:

Biocompatibles UK LtdBoston Scientific Corporation
Collaborated on 1 trial
Similarity Score14%

Ahsun Riaz, MD

Northwestern University

Related
1 trials

Shared therapeutic areas:

Benign Prostatic Hyperplasia

Worked with same sponsors:

BTG International Inc.Northwestern University
Collaborated on 1 trial
Similarity Score14%

Etienne Garin, MD

Centre Eugène Marquis

Related
1 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular

Worked with same sponsors:

Biocompatibles UK LtdBoston Scientific Corporation
Collaborated on 1 trial
Similarity Score14%

Hugo de Jong, PhD

Universitair Medisch Centrum Utrecht

Related
1 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular

Worked with same sponsors:

Biocompatibles UK LtdBoston Scientific Corporation
Collaborated on 1 trial
Similarity Score14%

Samdeep Mouli, MD

Northwestern University

Related
1 trials

Shared therapeutic areas:

Benign Prostatic Hyperplasia

Worked with same sponsors:

BTG International Inc.Northwestern University
Collaborated on 1 trial
Similarity Score14%

Matthias Hofer, MD

Northwestern University

Related
1 trials

Shared therapeutic areas:

Benign Prostatic Hyperplasia

Worked with same sponsors:

BTG International Inc.Northwestern University
Collaborated on 1 trial
Similarity Score14%

Vincenzo Mazzaferro, MD

Istituto Tumori Nazionale, Milan, Italy

Related
1 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular

Worked with same sponsors:

Biocompatibles UK LtdBoston Scientific Corporation
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05233098PrincipalInvestigator

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma
Completed
NCT03052049Not ApplicablePrincipalInvestigator

Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres

Benign Prostatic Hyperplasia (BPH)
Completed
NCT03059030Not ApplicablePrincipalInvestigator

Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia

CirrhosisThrombocytopenia
Terminated
NCT03295006PrincipalInvestigator

A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC

Hepatocellular Carcinoma
Completed
NCT01887717Phase 3PrincipalInvestigator

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Hepatocellular Carcinoma
Terminated
NCT00956930Phase 2PrincipalInvestigator

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Liver Cancer
Completed

All 6 trials loaded